David M. Goldenberg
2016
In 2016, David M. Goldenberg earned a total compensation of $4.2M as Chairman, Chief Scientific Officer and Chief Patent Officer at Immunomedics, a 188% increase compared to previous year.
Compensation breakdown
| Salary | $626,126 |
|---|---|
| Stock Awards | $3,420,000 |
| Other | $153,313 |
| Total | $4,199,439 |
Goldenberg received $3.4M in stock awards, accounting for 81% of the total pay in 2016.
Goldenberg also received $626.1K in salary and $153.3K in other compensation.
Rankings
In 2016, David M. Goldenberg's compensation ranked 2,068th out of 14,075 executives tracked by ExecPay. In other words, Goldenberg earned more than 85.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,068 out of 14,075 | 85th |
Division Manufacturing | 711 out of 5,489 | 87th |
Major group Chemicals And Allied Products | 206 out of 1,895 | 89th |
Industry group Drugs | 148 out of 1,538 | 90th |
Industry In Vitro and In Vivo Diagnostic Substances | 3 out of 65 | 95th |
Source: SEC filing on November 2, 2016.
Goldenberg's colleagues
We found three more compensation records of executives who worked with David M. Goldenberg at Immunomedics in 2016.